tradingkey.logo
tradingkey.logo
Search

Basel Medical Group Ltd

BMGL
Add to Watchlist
0.656USD
-0.044-6.26%
Close 05/15, 16:00ETQuotes delayed by 15 min
12.33MMarket Cap
LossP/E TTM

Basel Medical Group Ltd

0.656
-0.044-6.26%

More Details of Basel Medical Group Ltd Company

Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Basel Medical Group Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. It also specializes in diagnostic imaging and outpatient care.

Basel Medical Group Ltd Info

Ticker SymbolBMGL
Company nameBasel Medical Group Ltd
IPO dateFeb 25, 2025
CEOChhoa (Yen Feng)
Number of employees77
Security typeOrdinary Share
Fiscal year-endFeb 25
Address600 North Bridge Road, #12-02/03
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountrySingapore
Postal code188778
Phone6562919188
Websitehttps://www.baselmedical.com
Ticker SymbolBMGL
IPO dateFeb 25, 2025
CEOChhoa (Yen Feng)

Company Executives of Basel Medical Group Ltd

Name
Name/Position
Position
Shareholding
Change
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Kwek Yoon Soong
Mr. Kwek Yoon Soong
Independent Director
Independent Director
--
--
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Kwek Yoon Soong
Mr. Kwek Yoon Soong
Independent Director
Independent Director
--
--
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, May 9
Updated: Sat, May 9
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Rainforest Capital VCC
54.32%
XTX Markets LLC
0.16%
Citadel Advisors LLC
0.13%
Susquehanna International Group, LLP
0.08%
T3 Companies, LLC
0.08%
Other
45.22%
Shareholders
Shareholders
Proportion
Rainforest Capital VCC
54.32%
XTX Markets LLC
0.16%
Citadel Advisors LLC
0.13%
Susquehanna International Group, LLP
0.08%
T3 Companies, LLC
0.08%
Other
45.22%
Shareholder Types
Shareholders
Proportion
Corporation
54.32%
Hedge Fund
0.21%
Investment Advisor
0.20%
Venture Capital
0.16%
Research Firm
0.09%
Investment Advisor/Hedge Fund
0.04%
Bank and Trust
0.03%
Other
44.95%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
22
136.26K
0.73%
-284.73K
2025Q4
14
296.50K
0.70%
--
2025Q3
14
296.50K
0.70%
+165.18K
2025Q2
6
124.34K
0.00%
+124.34K
2025Q1
5
12.74M
67.81%
+12.74M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Rainforest Capital VCC
10.21M
54.32%
+30.65K
+0.30%
Nov 17, 2025
XTX Markets LLC
30.43K
0.16%
+30.43K
--
Dec 31, 2025
Citadel Advisors LLC
24.67K
0.13%
-68.33K
-73.47%
Dec 31, 2025
Susquehanna International Group, LLP
15.29K
0.08%
+15.29K
--
Dec 31, 2025
Renaissance Technologies LLC
14.50K
0.08%
+14.50K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
6.97K
0.04%
--
--
Jan 31, 2026
UBS Financial Services, Inc.
8.09K
0.04%
+2.19K
+37.12%
Dec 31, 2025
Coston, McIsaac & Shea Financial Advisors
50.00
0%
--
--
Dec 31, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI